Fortis Healthcare Sees Sharp Open Interest Surge Amid Mixed Market Signals

Open Interest and Volume Dynamics

On 25 Mar 2026, Fortis Healthcare’s open interest (OI) in derivatives rose sharply to 30,384 contracts from 25,881 the previous day, marking an increase of 4,503 contracts or 17.4%. This surge in OI was accompanied by a volume of 13,102 contracts, indicating robust trading activity. The futures segment alone accounted for a value of approximately ₹69,649 lakhs, while options contributed a staggering ₹1,524.76 crores, culminating in a total derivatives value of ₹69,819 lakhs.

The underlying stock price closed at ₹829, having touched an intraday high of ₹833, up 2.66% on the day. Notably, the stock has been on a two-day consecutive gain streak, delivering a cumulative return of 3.27%. However, it marginally underperformed its hospital sector peers, which gained 2.38% on the same day, and lagged slightly behind the Sensex’s 1.97% rise.

Market Positioning and Investor Sentiment

The sharp rise in open interest alongside increased volume points to a growing investor interest in Fortis Healthcare’s derivatives, possibly reflecting a mix of speculative directional bets and hedging activities. The stock’s mojo score currently stands at 30.0 with a mojo grade of Sell, downgraded from Hold on 6 Mar 2026, signalling a cautious stance from the market analytics perspective.

Despite the recent price gains, the stock remains below its 20-day, 50-day, 100-day, and 200-day moving averages, suggesting that the broader trend remains subdued. The 5-day moving average is the only short-term technical indicator that the stock has surpassed, indicating some near-term momentum but not yet a confirmed uptrend.

Investor participation has also risen, with delivery volumes on 24 Mar reaching 15.66 lakh shares, a 21.05% increase over the five-day average delivery volume. This heightened participation underscores growing interest in the stock, although the liquidity profile, with a trade size capacity of ₹3.58 crores based on 2% of the five-day average traded value, suggests moderate ease of trading for institutional investors.

Interpreting the Derivatives Activity

The 17.4% increase in open interest is a notable development, especially when paired with the rising volume and modest price appreciation. Such a pattern often indicates that new positions are being established rather than existing ones being closed out. This can be interpreted as fresh directional bets being placed by traders and investors.

Given the stock’s mojo grade downgrade to Sell, it is plausible that a significant portion of the derivatives activity is driven by bearish positioning or protective hedging. However, the stock’s recent two-day gain and intraday highs suggest that some participants may be speculating on a short-term rebound or volatility-driven opportunities.

Options value dominating the derivatives turnover at ₹1,524.76 crores compared to futures at ₹69,649 lakhs highlights the preference for more flexible strategies, such as buying calls or puts, or writing options to generate premium income. This complexity in positioning can often precede significant price moves as market participants adjust their exposures.

Sector and Market Context

Fortis Healthcare operates within the hospital and healthcare services sector, which has gained 2.38% on the day, outperforming the stock’s 2.10% return. The sector’s relative strength suggests positive sentiment towards healthcare services, possibly driven by broader macroeconomic or policy factors.

However, Fortis’s mid-cap status with a market capitalisation of ₹62,540.73 crores places it in a competitive bracket where investor expectations for growth and stability are high. The stock’s inability to surpass longer-term moving averages may be a reflection of underlying concerns or profit-taking at higher levels.

Investors should also note the stock’s liquidity profile, which supports moderate trade sizes but may limit large-scale institutional manoeuvres without impacting price significantly.

Investor Takeaways and Outlook

The recent surge in open interest and volume in Fortis Healthcare’s derivatives market signals increased investor engagement and a possible shift in market sentiment. While the stock has shown short-term strength, the downgrade to a Sell mojo grade and its position below key moving averages counsel caution.

Market participants should closely monitor the evolution of open interest and price action in the coming sessions to discern whether the current activity represents a genuine turnaround or a transient volatility spike. The dominance of options activity suggests that traders are positioning for potential volatility, which could lead to wider price swings.

Given the hospital sector’s overall positive momentum, Fortis Healthcare’s performance will likely hinge on company-specific developments and broader healthcare trends. Investors with a higher risk appetite may consider tactical exposure through derivatives, while long-term investors might await clearer confirmation of trend reversal before increasing holdings.

In summary, the derivatives market activity around Fortis Healthcare reflects a nuanced market view, blending cautious optimism with hedging strategies amid a mixed technical backdrop.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today